เอกสารอ้างอิง
1.Copelan E, Avalos B, Friend R. Assessment of neutropenia.BMJ Best Practice 2016.Available from http://bestpractice.bmj.com/best-practice/monograph-pdf/893.cited 12 Jul 2020.
2.Methotrexate |AccessMedicine|McGraw-Hill Medical[internet].Available from: https://accessmedicine.mhmedical.com/drugs.aspx?gbosID=426773#monoNumber=426773§ionID=243257601&tab=tab0.cited 12 Jul 2020.
3.U. S. Food and Drug Administration.filgrastim.[internet].Available from https://www.accessdata.fda.gov/drugsatfda_docs/label/1998/filgamg040298lb.cited 12 Jul 2020.
4.Caselli D, Cesaro S, Aricò M.Biosimilars in the management of neutropenia: focus on filgrastim.Biologics.2016.
5.Andrès E, Kurtz JE, Martin-Hunyadi C, et al. Nonchemotherapy drug-induced agranulocytosis in elderly patients: the effects of granulocyte colony-stimulating factor.Am J Med.2002.